Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A. S. Zamedyanskaya"'
Autor:
A. S. Zamedyanskaya, Al. A. Sergeev, K. A. Titova, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, A. E. Nesterov, O. V. Nosareva, D. O. Galakhova, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 75-78 (2016)
Objective of the study is to investigate the sensitivity of different animals to highly pathogenic Orthopoxviruses applying techniques, based on utilization of primary cultures of lung cells, and to assess the possibility of further deployment of thi
Externí odkaz:
https://doaj.org/article/dd9f597aece14c038df1adf618d2cad7
Autor:
D. O. Galakhova, Ar. A. Sergeev, E. V. Shevtsova, Al. A. Sergeev, A. S. Zamedyanskaya, K. A. Titova, L. N. Shishkina, L. E. Bulychev, S. V. Borisevich, V. N. Podkuiko, A. P. Pirozhkov, A. V. Koval’Chuk, Ya. V. Polyansky, E. Yu. Vakhnov, V. V. Perekrest, V. A. Shevtsov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 1, Pp 84-89 (2016)
Objective of the investigation was to model the adverse action of vaccinia virus (VV), caused by oral immunization of mice and to evaluate efficacy of its reduction, using therapeutic and prophylactic drugs. Materials and methods. Virological and imm
Externí odkaz:
https://doaj.org/article/2f2e4a61775149329dc1cadbb24582a5
Autor:
K. A. Titova, Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, D. O. Galahova, A. S. Zamedyanskaya, L. N. Shishkina, O. S. Taranov, V. V. Omigov, E. L. Zavjalov, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Вавиловский журнал генетики и селекции, Vol 19, Iss 4, Pp 487-493 (2015)
At present, there is no animal model for smallpox that reflects the weakened immune system in people and can therefore help assess the prophylactic (highly preventive) efficiency of antiviral drugs. To fill in the gap, we have explored the possibilit
Externí odkaz:
https://doaj.org/article/9bb5088aad6642b2a9041610de31713f
Autor:
Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. P’Yankov, Ar. A. Sergeev, S. A. Bodnev, D. O. Gorbatovskaya, A. S. Zamedyanskaya, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Проблемы особо опасных инфекций, Vol 0, Iss 4, Pp 86-90 (2015)
By the experiments of in vivo intranasal infection of 8-10-days-old outbread ICR mice with Monkeypox virus (MPV) in a dose equal 3.83 lg FFU/specimen, investigated was dynamics of the virus accumulation within various organs, blood cells, and blood s
Externí odkaz:
https://doaj.org/article/31647faedd1e46d4a264605086d2cff7
Autor:
Sergeev An, Bulychev Le, K. A. Titova, O. S. Taranov, Ar. A. Sergeev, A. S. Zamedyanskaya, Alexander P. Agafonov, Omigov Vv, E. L. Zavjalov, Larisa N. Shishkina, Sergeev Aa, D. O. Gorbatovskaya, A. S. Kabanov
Publikováno v:
Russian Journal of Genetics: Applied Research. 6:477-484
There is currently no animal model to evaluate the preventive efficacy of antiviral drugs for the treatment of smallpox in human patients with a weak immune system. Therefore, the possibility of using outbred severe combined immunodeficiency (SCID) m
Autor:
Alena S. Zamedyanskaya, Alexander P. Agafonov, Omigov Vv, A. S. Kabanov, Darya O. Galahova, A. A. Sergeev, O. S. Taranov, Tanyana I. Glotova, K. A. Titova, Alexander A. Sergeev, Anastasia A. Morozova, E. L. Zavjalov, Bulychev Le, Larisa N. Shishkina, Sergeev An
Publikováno v:
Journal of General Virology. 96:2832-2843
The possibility of using immunocompetent ICR mice and immunodeficient SCID mice as model animals for smallpox to assess antiviral drug efficacy was investigated. Clinical signs of the disease did not appear following intranasal (i.n.) challenge of mi
Autor:
A. A. Sergeev, A. S. Kabanov, L. E. Bulychev, O. V. Pyankov, S. A. Bodnev, D. O. Galahova, A. S. Zamedyanskaya, K. A. Titova, T. I. Glotova, O. S. Taranov, V. V. Omigov, L. N. Shishkina, A. P. Agafonov, A. N. Sergeev
Publikováno v:
Europe PubMed Central
Summary In experiments to study the sensitivity of ground squirrels (Marmota bobak) to monkeypox virus (MPXV) at intranasal challenge, expressed pox-like clinical symptoms (hyperthermia, lymphadenitis, skin rash all over the body and mucous membranes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e35f819914ad1449b45e0a658b7221a
http://europepmc.org/abstract/med/25944444
http://europepmc.org/abstract/med/25944444
Autor:
Bodnev Sa, Darya O. Galahova, Ar. A. Sergeev, Sergeev Aa, A. S. Zamedyanskaya, O. S. Taranov, A. G. Glotov, A. S. Kabanov, K. A. Titova, Oleg V. Pyankov, Bulychev Le, Sergeev An, Alexander P. Agafonov, Omigov Vv, Larisa N. Shishkina
Publikováno v:
Europe PubMed Central
Summary As a result of the conducted experimental studies on intranasal challenge of ICR mice, rabbits and miniature pigs (even in the maximum variant) with the doses of 4.0–5.5 lg PFU of monkeypox virus (MPXV), some clinical signs such as purulent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c901723e54a6f2639b23a018fce756e9
http://europepmc.org/abstract/med/25597343
http://europepmc.org/abstract/med/25597343